rs764066045
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_178452.6(DNAAF1):c.1645-2A>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000889 in 1,461,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_178452.6 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.1645-2A>C | splice_acceptor_variant, intron_variant | Intron 9 of 11 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.1645-2A>C | splice_acceptor_variant, intron_variant | Intron 9 of 11 | 1 | NM_178452.6 | ENSP00000367815.5 | |||
DNAAF1 | ENST00000570298.5 | n.4090A>C | non_coding_transcript_exon_variant | Exon 9 of 11 | 2 | |||||
DNAAF1 | ENST00000563093.5 | n.*200-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 10 | 2 | ENSP00000457373.1 | ||||
DNAAF1 | ENST00000563818.5 | n.1322-2A>C | splice_acceptor_variant, intron_variant | Intron 5 of 7 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251466Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135920
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461866Hom.: 0 Cov.: 35 AF XY: 0.00000825 AC XY: 6AN XY: 727236
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1Uncertain:1
The c.1645-2A>C intronic variant results from an A to C substitution two nucleotides upstream from coding exon 10 in the DNAAF1 gene. Alterations that disrupt the canonical splice site are expected to result in aberrant splicing. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. The resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNAdecay; however, direct evidence is unavailable. The exact functional effect of the altered amino acid sequence is unknown. This nucleotide position is highly conserved in available vertebrate species. Based on the available evidence, the clinical significance of this variant remains unclear. -
This sequence change affects an acceptor splice site in intron 9 of the DNAAF1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DNAAF1 are known to be pathogenic (PMID: 19944400, 19944405). This variant is present in population databases (rs764066045, gnomAD 0.03%). Disruption of this splice site has been observed in individual(s) with primary ciliary dyskinesia (internal data). ClinVar contains an entry for this variant (Variation ID: 455001). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at